Characterization of Hepatitis C Virus genotype 3a Hypervariable region 1 in patients achieved rapid virological response to alpha interferon and Ribavirin Combination therapy

BACKGROUND: Hepatitis C virus roots a chronic liver disease. Currently approved treatment strategy includes administration of alpha interferon and ribavirin combined therapy for 24-48 weeks. One of the predictor of sustained virological response is an early virological response to treatment characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Akram, Madiha, Idrees, Muhammad, Hussain, Abrar, Afzal, Samia, Ilyas, Muhammad, Zafar, Shamail, Aftab, Mahwish, Badar, Sadaf, Khubaib, Bushra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117844/
https://www.ncbi.nlm.nih.gov/pubmed/21605410
http://dx.doi.org/10.1186/1743-422X-8-253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117844/
https://www.ncbi.nlm.nih.gov/pubmed/21605410
http://dx.doi.org/10.1186/1743-422X-8-253

Ejemplares similares